A side effect of a   drug that was originally used as an immunosuppressive could one day be used to deal baldness .

researcher have found that the fighting compoundstimulates human hair folliclesto grow by target a protein that usually place the breaks on . Publishing their results in the journalPlos Biology , they desire that it can now be developed into a class that could be used to treat alopecia .

“ The fact this new factor , which had never even been considered in a hair loss context , promotes human hair growth is exciting because of its translational potential drop : it could one day make a real remainder to people who suffer from hair release , ” said the University of Manchester ’s Dr Nathan Hawkshaw , who co - authored the cogitation , instatement .

The drug was really to begin with plan to treat transplant patients , to suppress transplantation rejection and autoimmune diseases . know officially as Cyclosporine A ( CsA ) , it has been unremarkably used since the 1980s , and does , unfortunately , have many side effects . One of the least serious – but most interesting – of these is the fact that it can sometimes cause unwanted hair growth .

The squad first set about trying to figure out the molecular mechanics of the drug , before then carry out a full gene expression psychoanalysis of individual human haircloth follicles , donate by citizenry undergo hair transplants , which had been treat with CsA. They were able to show that the drug inhibited a particular gene , SFRP1 , which has in previous discipline been shown to conquer the growth of tissues , most crucially include hair follicle .

If this could be developed into an effective treatment , then it could have a significant wallop on those suffering from hair personnel casualty , which for many can do psychological and mental distress . presently , intervention is very limited , with patients either let to take one of two drugs – minoxidil and finasteride – or go under the tongue and get a hairsbreadth transplant . While the latter is often quite successful , it is obviously quite encroaching , while the two drug often have mixed results .

The discovery that CsA could potentially offer a fourth result is exciting . “ clear though , a clinical tribulation is required next to state us whether this drug or similar compound are both effective and safe in hair loss patients , ” Dr Hawkshaw pointed out . But for hoi polloi who suffer from whisker passing , sleep together new avenues are open to research a remedy will be a relief .